SWISS to Cure DIPG

📍 Zurich, Switzerland🗓 Founded 2022👥 2 employees
Founded in 2022, the "SWISS to cure DIPG" foundations main goal is to serve children and families, diagnosed with the deadliest DIPG/ DMG* cancer among children and adolescents, as well as the wider dedicated medical community. The founders started funding the DIPG/DMG Center in Zurich to: -Expend and speed-up research and treatments for this devastating cancer; offer personalized precision medicine; -Give all children access to top-experts and top clinical-trials; -Raise awareness & support where governments and industry do not see profits, are too slow or just ignore the need. *Diffuse Intrinsic Pontine Glioma (DIPG) / Diffuse Midline Glioma (DMG)
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was SWISS to Cure DIPG founded?
SWISS to Cure DIPG was founded in 2022.
What industry is SWISS to Cure DIPG in?
SWISS to Cure DIPG operates in Non-profit Organizations. Find similar Non-profit Organizations investors on gritt.io.
Where is SWISS to Cure DIPG based?
SWISS to Cure DIPG is headquartered in Zurich, Switzerland.